Nephrolithiasis clinical trials
47 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Tract Closure in PCNL
- Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology
- Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)
- Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study
- Comparing Efficiency and Stone-Free Rates Mini PCNL vs Flex URS
- Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
- Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
- Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
- Dexamethasone for Ureteral STent Symptoms (DUSTS)
- HoYAG vs TFL in miniPCNL With ClearPetra
- The Use of AR / VR in Patients Presenting to the ED With Renal Colic
- Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
- Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
- Randomized Controlled Trial of Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths Versus Conventional Sheaths for Treatment of Nephrolithiasis
- Surgical Outcomes and Costs in Using the Shenzhen HugeMed 6.3 French Flexible Ureteroscope
- Oxalate and Citrate in Humans - Response to Citrate
- Oxalate and Citrate
- CaOx Stone Prevention
- Fecal Microbiota Transplantation in Kidney Stone Patients
- Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease
- GI Oxalate Absorption
- Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
- RETRO Study (RETrograde Renal Access Outcomes)
- Kidney Stone Inflammation
- Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
- Stone and Laser Therapies Post-Market Study (SALT)
- Evaluation of Eye Gaze Sharing in the Operating Room
- O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
- Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
- Gut Oxalate Absorption in Calcium Oxalate Stone Disease
- Access Sheath and Stent Trial
- ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy
- NSAIDs Stent Study
- Oxalate-Driven Host Responses in Kidney Stone Disease
- FANS vs CVAC for Medium to Large Stones
- Prospective Multi-center Study Comparing Pulsed Tm:YAG Laser to Pulse Modulated Holmium Laser in the Treatment of Nephrolithiasis With FANS Access Sheaths
- Sodium Bicarbonate as an Alternative to Potassium Citrate for Kidney Stones
- The LARC Robot Simplifies Renal Access In Percutaneous Nephrolithotomy
- Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet
- Observational Approach Versus Surgical Intervention for Stones
- The Effect of Apple Cider Vinegar Supplementation on 24-hour Urine Chemistry in Adults
- Pilot Study of Patient Navigation for Kidney Stone Patients After ED Visits
- Heterozygous Individuals for AGXT and Kidney Stones
- Meditation Effects on Discomfort, Pain InTerference, and AnxieTy After urEteroscopy
- Comparison of Holmium Laser and Thulium Laser for Mini PCNL
- Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off
- Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Nephrolithiasis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.